PALO ALTO, Calif., May 4 "BIO has long been a strong and outspoken advocate for the critical, game-changing work of the biotechnology sector. It is my goal to build upon these achievements and push forward, with my Board colleagues, an aggressive agenda that fosters the right policy environment for the biobased solutions that our industry brings to the market.
This is an important year. I am convinced we are at a tipping point - a moment in history where industry and government need to align like never before to ensure that we are creating the right conditions to solve the most pressing issues of our time - energy security, food security and climate change challenges for a growing world."
Genencor, a division of Danisco A/S, is a world leader in industrial biotechnology and a pioneer in enzyme innovation. Genencor improves process and product performance for a spectrum of industries. As part of a large global organization, Genencor has a manufacturing and distribution network that spans more than 40 countries. In collaboration with customers, technology leaders and other stakeholders, Genencor supplies competitive, biobased solutions. These innovations create value throughout the supply chain, from raw material to finished product.
For more information visit http://www.genencor.com.
BIO is the world's largest organization representing the global biotechnology community, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. Corporate members range from entrepreneurial companies developing a first product to Fortune 500 multinationals, state and regional biotech associations, service providers to the industry, and academic centers. The mission of BIO is to be the champion of biotechnology and the advocate for its member organizations - both large and small.